Evommune OverviewEvommune EBIT
EBIT (Earnings Before Interest and Taxes) analysis for EVMN.
Quarterly EBIT
-$23.95M
↓ 64.6% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$79.71M
↓ 25.16% YoY
Trailing 12 months ending Mar 31, 2026
Evommune OverviewEBIT (Earnings Before Interest and Taxes) analysis for EVMN.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026